{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:01:37Z","timestamp":1761487297670},"reference-count":24,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.tube.2004.09.013","type":"journal-article","created":{"date-parts":[[2005,1,25]],"date-time":"2005-01-25T14:49:35Z","timestamp":1106664575000},"page":"107-114","source":"Crossref","is-referenced-by-count":33,"title":["Nasal boost with adjuvanted heat-killed BCG or arabinomannan\u2013protein conjugate improves primary BCG-induced protection in C57BL\/6 mice"],"prefix":"10.1016","volume":"85","author":[{"given":"M.","family":"Haile","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Hamasur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Jaxmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Gavier-Widen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"K\u00e4llenius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.B.","family":"Svenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Pawlowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2004.09.013_bib1","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.271.9.698","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.tube.2004.09.013_bib2","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.tube.2004.09.013_bib3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0966-842X(00)01949-1","article-title":"Tuberculosis vaccine development","volume":"9","author":"Orme","year":"2001","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.tube.2004.09.013_bib4","doi-asserted-by":"crossref","unstructured":"Karonga Prevention Trial Group. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for the prevention of leprosy and tuberculosis in Malawi. Lancet 1996; 348:17\u201324.","DOI":"10.1016\/S0140-6736(96)02166-6"},{"key":"10.1016\/j.tube.2004.09.013_bib5","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1365-3016.1993.tb00408.x","article-title":"The decline of BCG immunity after neonatal vaccination","volume":"7","author":"Aydinlioglu","year":"1993","journal-title":"Paediatr Perinat Epidemiol"},{"key":"10.1016\/j.tube.2004.09.013_bib6","first-page":"200","article-title":"Does the efficacy of BCG decline with time since vaccination?","volume":"2","author":"Sterne","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.tube.2004.09.013_bib7","unstructured":"WHO Global Tuberculosis Programme on Vaccines. Statement on BCG revaccination for the prevention of tuberculosis. WHO Weekly Epidem Rec 1995; 70:229\u201331."},{"key":"10.1016\/j.tube.2004.09.013_bib8","first-page":"717","article-title":"Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong","volume":"5","author":"Leung","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.tube.2004.09.013_bib9","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0962-8479(92)90043-J","article-title":"Case-control study of the efficacy of BCG immunization against pulmonary tuberculosis in young adults in Santiago","volume":"73","author":"Sepulveda","year":"1992","journal-title":"Chile Tuberc Lung Dis"},{"key":"10.1016\/j.tube.2004.09.013_bib10","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.vaccine.2003.10.016","article-title":"Immunization with heat killed Mycobacterium bovis Bacille Calmette\u2013Gu\u00e9rin (BCG) in Eurocine\u2122 L3 adjuvant protects against tuberculosis","volume":"22","author":"Haile","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2004.09.013_bib11","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1016\/S0264-410X(03)00274-3","article-title":"Mycobacterium tuberculosis arabinomannan\u2013protein conjugates protect against tuberculosis","volume":"21","author":"Hamasur","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2004.09.013_bib12","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1016\/S0264-410X(99)00124-3","article-title":"Synthesis and immunologic characterization of Mycobacterium tuberculosis lipoarabinomannan specific oligosaccharide\u2013protein conjugates","volume":"17","author":"Hamasur","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2004.09.013_bib13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1046\/j.1365-2249.2003.02171.x","article-title":"A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes","volume":"133","author":"Lopez","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.tube.2004.09.013_bib14","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1365-2249.2004.02551.x","article-title":"Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with different Mycobacterium tuberculosis genotypes in a BALB\/c mouse model","volume":"137","author":"Dormans","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.tube.2004.09.013_bib15","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1128\/IAI.69.4.2714-2717.2001","article-title":"Boosting vaccine for tuberculosis","volume":"69","author":"Brooks","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2004.09.013_bib16","doi-asserted-by":"crossref","first-page":"5921","DOI":"10.4049\/jimmunol.165.10.5921","article-title":"Comparative analysis of T lymphocytes recovered from the lungs of mice genetically susceptible, resistant, and hyperresistant to Mycobacterium tuberculosis-triggered disease","volume":"165","author":"Lyadova","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2004.09.013_bib17","doi-asserted-by":"crossref","first-page":"5266","DOI":"10.1128\/IAI.71.9.5266-5272.2003","article-title":"SWR mice are highly susceptible to pulmonary infection with Mycobacterium tuberculosis","volume":"71","author":"Turner","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2004.09.013_bib18","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1046\/j.1365-2567.2003.01727.x","article-title":"Characterization of CC-chemokine receptor 7 expression on murine T cells in lymphoid tissues","volume":"110","author":"Bjorkdahl","year":"2003","journal-title":"Immunology"},{"key":"10.1016\/j.tube.2004.09.013_bib19","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1086\/344359","article-title":"Investigation of the relationships between immune-mediated inhibition of mycobacterial growth and other potential surrogate markers of protective Mycobacterium tuberculosis immunity","volume":"186","author":"Hoft","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tube.2004.09.013_bib20","doi-asserted-by":"crossref","first-page":"6411","DOI":"10.1128\/IAI.71.11.6411-6419.2003","article-title":"Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination","volume":"71","author":"Buddle","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2004.09.013_bib21","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1046\/j.1365-2567.2003.01589.x","article-title":"A DNA prime-live vaccine boost strategy in mice can augment IFN-\u03b3 responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis","volume":"108","author":"Skinner","year":"2003","journal-title":"Immunology"},{"key":"10.1016\/j.tube.2004.09.013_bib22","doi-asserted-by":"crossref","first-page":"11497","DOI":"10.1073\/pnas.201404898","article-title":"Divergent effect of Bacillus Calmette\u2013Gu\u00e9rin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species","volume":"98","author":"Langermans","year":"2001","journal-title":"Proc Natl Acad Sci, USA"},{"key":"10.1016\/j.tube.2004.09.013_bib23","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1128\/IAI.70.6.3026-3032.2002","article-title":"Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis","volume":"70","author":"Vordermeier","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2004.09.013_bib24","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.171.3.1602","article-title":"Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette\u2013Gu\u00e9rin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara","volume":"171","author":"Goonetilleke","year":"2003","journal-title":"J Immunol"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147297920400085X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147297920400085X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T23:20:08Z","timestamp":1548804008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147297920400085X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":24,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S147297920400085X"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2004.09.013","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}